{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:15:23Z","timestamp":1778602523514,"version":"3.51.4"},"reference-count":39,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"unspecified","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["25ZR1401313"],"award-info":[{"award-number":["25ZR1401313"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013314","name":"National 111 Project of China","doi-asserted-by":"crossref","award":["B21024"],"award-info":[{"award-number":["B21024"]}],"id":[{"id":"10.13039\/501100013314","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-KJFZMSX0044"],"award-info":[{"award-number":["CSTB2024NSCQ-KJFZMSX0044"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["W2431055"],"award-info":[{"award-number":["W2431055"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Peak Disciplines (Type IV) of Institutions of Higher Learning in Shanghai","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People\u2019s Republic of China","doi-asserted-by":"crossref","award":["2023YFC3404101"],"award-info":[{"award-number":["2023YFC3404101"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Jiading District Health Commission","award":["2025-KY-ZD-05"],"award-info":[{"award-number":["2025-KY-ZD-05"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2026,4,30]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Major histocompatibility complex class I (MHC)-I loss is a prevalent mechanism for immune evasion and resistance to immunotherapy. However, how MHC-I loss shapes the tumor microenvironment and influences immune cell interactions, ultimately affecting tumor growth, remains largely unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We established\n                      <jats:italic>B2m<\/jats:italic>\n                      knockout (MHC-I-deficient) tumor cells using CRISPR\/Cas9 and evaluated their growth in subcutaneous and orthotopic mouse models. Immune profiling was performed using flow cytometry and single-cell RNA sequencing. Antibody-mediated cell depletion was used to assess the functional contributions of specific immune subsets. Chemokine expression was analyzed by bulk RNA sequencing, quantitative PCR, ELISA and western blotting, and its functional relevance was determined using knockout or overexpression in tumor cells implanted in vivo. Signaling pathways were interrogated using pharmacological inhibition, RNA interference and western blotting.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      MHC-I loss promoted tumor growth in MC38, AKR, and LLC1 models, but unexpectedly suppressed Hepa1-6 and orthotopic\n                      <jats:italic>MYC;Trp53<\/jats:italic>\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      hepatocarcinoma growth. This differential effect correlated with changes in immune infiltrates. CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells, natural killer (NK) cells, and macrophages were required for suppression of MHC-I-deficient Hepa1-6 tumors. CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells were essential for recruiting NK cells and monocytes\/macrophages and for inducing their tumoricidal phenotypes, including iNOS (inducible nitric oxide synthase) expression in macrophages. The differential infiltration of CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells was driven by opposite regulation of CXCL16 on\n                      <jats:italic>B2m<\/jats:italic>\n                      knockout: upregulation in Hepa1-6 cells and downregulation in other models. CXCL16 exerted potent antitumor effects by recruiting CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells. Mechanistically, B2M loss regulated CXCL16 via suppression of Akt in MC38 and AKR cells, but via activation of NF-\u03baB in Hepa1-6 cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      CXCL16-driven CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells are central regulators of antitumor immunity against MHC-I-deficient tumors. The context-dependent regulation of CXCL16 by MHC-I loss determines the immune landscape and tumor outcome, highlighting a potential therapeutic avenue for targeting MHC-I-deficient cancers.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2025-012347","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:51:27Z","timestamp":1778601087000},"page":"e012347","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["CXCL16-driven CD4\n                    <sup>+<\/sup>\n                    T cells orchestrate immunosurveillance against MHC-I-deficient hepatocellular tumors"],"prefix":"10.1136","volume":"14","author":[{"given":"Yunyi","family":"Zhou","sequence":"first","affiliation":[{"name":"Shanghai Key Laboratory for Cancer System Regulation and Clinical Translation, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China"},{"name":"School of Biomedical Engineering, Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[{"name":"Shanghai Key Laboratory for Cancer System Regulation and Clinical Translation, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixue","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Key Laboratory for Cancer System Regulation and Clinical Translation, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China"},{"name":"School of Biomedical Engineering, Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Gui","sequence":"additional","affiliation":[{"name":"Shanghai Key Laboratory for Cancer System Regulation and Clinical Translation, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengheng","family":"Zheng","sequence":"additional","affiliation":[{"name":"Shanghai Key Laboratory for Cancer System Regulation and Clinical Translation, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China"},{"name":"School of Biomedical Engineering, Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Qiang","family":"Gao","sequence":"additional","affiliation":[{"name":"School of Biomedical Engineering, Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China"},{"name":"State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5744-9667","authenticated-orcid":false,"given":"Bin","family":"Ma","sequence":"additional","affiliation":[{"name":"Shanghai Key Laboratory for Cancer System Regulation and Clinical Translation, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China"},{"name":"Chongqing Research Institute, Shanghai Jiao Tong University, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"2026051208502006000_14.5.e012347.1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0390-6"},{"key":"2026051208502006000_14.5.e012347.2","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002899","article-title":"Deregulation of HLA-I in cancer and its central importance for immunotherapy","volume":"9","author":"Hazini","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2026051208502006000_14.5.e012347.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00789-4"},{"key":"2026051208502006000_14.5.e012347.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-017-0004-z"},{"key":"2026051208502006000_14.5.e012347.5","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00732-1"},{"key":"2026051208502006000_14.5.e012347.6","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01267-2"},{"key":"2026051208502006000_14.5.e012347.7","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1016\/j.cell.2024.03.039","article-title":"IGSF8 is an innate immune checkpoint and cancer immunotherapy target","volume":"187","author":"Li","year":"2024","journal-title":"Cell"},{"key":"2026051208502006000_14.5.e012347.8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1158\/2159-8290.CD-23-0519","article-title":"NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer","volume":"14","author":"Taylor","year":"2024","journal-title":"Cancer Discov"},{"key":"2026051208502006000_14.5.e012347.9","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.117"},{"key":"2026051208502006000_14.5.e012347.10","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-1409"},{"key":"2026051208502006000_14.5.e012347.11","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0987"},{"key":"2026051208502006000_14.5.e012347.12","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1158\/2326-6066.CIR-23-0139","article-title":"Antitumor Immune Responses in B2M-Deficient Cancers","volume":"11","author":"Torrejon","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"2026051208502006000_14.5.e012347.13","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41586-023-06199-x","article-title":"CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours","volume":"618","author":"Kruse","year":"2023","journal-title":"Nature New Biol"},{"key":"2026051208502006000_14.5.e012347.14","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008917","article-title":"Protein O-fucosyltransferase 1 promotes PD-L1 stability to drive immune evasion and directs liver cancer to immunotherapy","volume":"12","author":"Li","year":"2024","journal-title":"J Immunother Cancer"},{"key":"2026051208502006000_14.5.e012347.15","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-0074"},{"key":"2026051208502006000_14.5.e012347.16","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/j.1460-2075.1988.tb02909.x","article-title":"c-myc down-regulates class I HLA expression in human melanomas","volume":"7","author":"Versteeg","year":"1988","journal-title":"EMBO J"},{"key":"2026051208502006000_14.5.e012347.17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.imlet.2023.04.009","article-title":"Tumor-associated NK cells facilitate tumor growth via NKp46 in immunocompetent murine hepatocellular carcinoma","volume":"258","author":"Guan","year":"2023","journal-title":"Immunol Lett"},{"key":"2026051208502006000_14.5.e012347.18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi2952","article-title":"Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6\/STAT3 axis","volume":"16","author":"Neo","year":"2024","journal-title":"Sci Transl Med"},{"key":"2026051208502006000_14.5.e012347.19","doi-asserted-by":"publisher","DOI":"10.1126\/science.ade2292"},{"key":"2026051208502006000_14.5.e012347.20","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.ymthe.2020.08.005","article-title":"Targeted Delivery of CXCL9 and OX40L by Mesenchymal Stem Cells Elicits Potent Antitumor Immunity","volume":"28","author":"Yin","year":"2020","journal-title":"Mol Ther"},{"key":"2026051208502006000_14.5.e012347.21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0465-5"},{"key":"2026051208502006000_14.5.e012347.22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/2051-1426-2-11","article-title":"Current status of granulocyte\u2013macrophage colony-stimulating factor in the immunotherapy of melanoma","volume":"2","author":"Kaufman","year":"2014","journal-title":"J Immunotherapy Cancer"},{"key":"2026051208502006000_14.5.e012347.23","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.4049\/jimmunol.1003713","article-title":"Macrophage Migration Inhibitory Factor and CD74 Regulate Macrophage Chemotactic Responses via MAPK and Rho GTPase","volume":"186","author":"Fan","year":"2011","journal-title":"The Journal of Immunology"},{"key":"2026051208502006000_14.5.e012347.24","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-019-0238-2"},{"key":"2026051208502006000_14.5.e012347.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.01.012"},{"key":"2026051208502006000_14.5.e012347.26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1022136","article-title":"CXCR6 expressing T cells: Functions and role in the control of tumors","volume":"13","author":"Mabrouk","year":"2022","journal-title":"Front Immunol"},{"key":"2026051208502006000_14.5.e012347.27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073490","article-title":"The Role of CXCL16 in the Pathogenesis of Cancer and Other Diseases","volume":"22","author":"Korbecki","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026051208502006000_14.5.e012347.28","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-051318"},{"key":"2026051208502006000_14.5.e012347.29","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s00262-019-02374-0","article-title":"CD4+ T cells indirectly kill tumor cells via induction of cytotoxic macrophages in mouse models","volume":"68","author":"Bogen","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"2026051208502006000_14.5.e012347.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2004.01.002"},{"key":"2026051208502006000_14.5.e012347.31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.trre.2011.04.001","article-title":"The link between major histocompatibility complex antibodies and cell proliferation","volume":"25","author":"Valenzuela","year":"2011","journal-title":"Transplant Rev (Orlando)"},{"key":"2026051208502006000_14.5.e012347.32","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1158\/0008-5472.CAN-22-0507","article-title":"\u03b22-Microglobulin Maintains Glioblastoma Stem Cells and Induces M2-like Polarization of Tumor-Associated Macrophages","volume":"82","author":"Li","year":"2022","journal-title":"Cancer Res"},{"key":"2026051208502006000_14.5.e012347.33","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2283"},{"key":"2026051208502006000_14.5.e012347.34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00167","article-title":"IFN-\u03c4 Mediated Control of Bovine Major Histocompatibility Complex Class I Expression and Function via the Regulation of bta-miR-148b\/152 in Bovine Endometrial Epithelial Cells","volume":"9","author":"Wu","year":"2018","journal-title":"Front Immunol"},{"key":"2026051208502006000_14.5.e012347.35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.605958"},{"key":"2026051208502006000_14.5.e012347.36","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.cell.2023.01.021","article-title":"\u03b22-microglobulin functions as an endogenous NMDAR antagonist to impair synaptic function","volume":"186","author":"Gao","year":"2023","journal-title":"Cell"},{"key":"2026051208502006000_14.5.e012347.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.07.015"},{"key":"2026051208502006000_14.5.e012347.38","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3437"},{"key":"2026051208502006000_14.5.e012347.39","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2017.016"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2025-012347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:51:31Z","timestamp":1778601091000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2025-012347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,12]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/jitc-2025-012347"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2025-012347","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}